Source author record

Philip Cooney

Philip Cooney appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
2topics
1close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2023arXiv

Extrapolation of Relative Treatment Effects using Change-point Survival Models

Introduction: Modelling of relative treatment effects is an important aspect to consider when extrapolating the long-term survival outcomes of treatments. Flexible parametric models offer the ability to accurately model the observed data, however, the extrapolated relative treatment effects and subsequent survival function may lack face validity. Methods: We investigate the ability of change-point survival models to estimate changes in the relative treatment effects, specifically treatment delay, loss of treatment effects and converging hazards. These models are implemented using standard Bayesian statistical software and propagate the uncertainty associate with all model parameters including the change-point location. A simulation study was conducted to assess the predictive performance of these models compared with other parametric survival models. Change-point survival models were applied to three datasets, two of which were used in previous health technology assessments. Results: Change-point survival models typically provided improved extrapolated survival predictions, particularly when the changes in relative treatment effects are large. When applied to the real world examples they provided good fit to the observed data while and in some situations produced more clinically plausible extrapolations than those generated by flexible spline models. Change-point models also provided support to a previously implemented modelling approach which was justified by visual inspection only and not goodness of fit to the observed data. Conclusions: We believe change-point survival models offer the ability to flexibly model observed data while also modelling and investigating clinically plausible scenarios with respect to the relative treatment effects.